Remote patient monitoring with a digital biomarker approach generates clinically distinctive and meaningful sensor feature data in Parkinson’s disease: Differential relationships with MDS-UPDRS-III, PDQ-39 and DaT-SPECT
Objective: To determine whether sensor features derived from remote smartphone testing in Parkinson’s disease (PD) predicted clinical, quality of life and biomarker measures collected in…Longitudinal MRI to predict cognitive impairment in Parkinson’s disease
Objective: To determine the value of MRI metrics in predicting global cognitive ability in Parkinson’s disease (PD). Background: Progressive cognitive impairment is a dominant feature…The study of 18F-FDG PET / CT imaging in the value on Parkinson’s disease
Objective: In this study,we were to investigate imaging characteristics of 18F-FDG PET/CT in patients with Parkinson's disease (PD), and explore its value on PD. Background:…Predictors and biomarkers of pain in newly diagnosed Parkinson’s disease patients during a two-year follow-up
Objective: To identify clinical characteristics, predictors and biomarkers of pain at baseline and after a two-year follow-up period in newly diagnosed drug-naïve Parkinson's Disease (PD)…Effect of bedtime levodopa/carpidopa/entacapone (Stalevo®) on sleep disturbance in patients with Parkinson’s disease with motor fluctuation
Objective: To investigate the efficacy of levodopa/carbidopa/entacapone (Stalevo®) at bedtime on sleep disturbance in patients with Parkinson’s disease (PD) who have motor fluctuation. Background: Sleep…Early stage Parkinson’s disease phenotypes
Objective: Identify Parkinson’s disease (PD) subpopulation clusters present at disease onset using a number of motor and non-motor phenotypes. Background: PD is considered a syndrome,…The association between pain and physical activity in people with Parkinson’s Disease (PD)
Objective: To determine the relationship between pain and physical activity in people with PD Background: Pain in PD is a serious problem that is usually…The role of DUODOPA Treatment on Non-Motor Symptoms, Specificly Autonomic Dysfunctions
Objective: The application of Duodopa in advanced Parkinson Disease (aPD) is quite new in the world and in Turkey. The main goal is to treat…Validation of the Hong Kong Chinese version of NMSQuest (HK-NMSQ)
Objective: This study aimed to translate and validate a standard Hong Kong Chinese version of the NMSQuest (HK-NMSQuest) to assist in identification of NMS in…Nonlinearities in outcome-specific hazard of motor and nonmotor long-term complications of Parkinson’s disease
Objective: To estimate the specific hazard of motor and nonmotor milestones of Parkinson's disease (PD) progression in the long term. Background: Parkinson’s disease greatly varies…
- « Previous Page
- 1
- …
- 49
- 50
- 51
- 52
- 53
- …
- 177
- Next Page »